Primelin, France

Florence L'Hospice

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Centre National De La Recherche Scientifique, Emergence Therapeutics Gmbh, Institut Jean Paoli & Irène Calmettes. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Florence L'Hospice. Retrieved from https://idiyas.com/inventor/florence-l-hospice

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Florence L'Hospice: Innovator in Antibody Research

Introduction

Florence L'Hospice is a prominent inventor based in Primelin, France. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies. Her work focuses on innovative solutions that address critical health challenges.

Latest Patents

Florence L'Hospice holds a patent for "Anti-nectin-4-antibodies and uses thereof." This invention relates to antibodies that specifically target Nectin-4, offering potential therapeutic applications in various medical conditions. The patent highlights her commitment to advancing scientific knowledge and improving patient outcomes.

Career Highlights

Throughout her career, Florence has worked with notable organizations, including Emergence Therapeutics GmbH and Université d'Aix-Marseille. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Florence has collaborated with esteemed colleagues such as Jack Elands and Xavier Préville. These partnerships have enriched her research and expanded the impact of her innovations in the scientific community.

Conclusion

Florence L'Hospice is a trailblazer in antibody research, with a focus on developing targeted therapies. Her contributions to the field exemplify the importance of innovation in addressing health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…